Global Sustained-release Medicine Market Growth (Status and Outlook) 2024-2030

2024

Global Sustained-release Medicine Market Growth (Status and Outlook) 2024-2030

Name: Global Sustained-release Medicine Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Sustained-release Medicine market, valued at US$34.09B in 2023, expected to reach US$55.27B by 2030, driven by increasing demand with 7.1% CAGR.

Bonafide Trust
04-01-2024
Pages : 105
Figures : 79
Tables : 115
Region : Global
Category : Lifescience
Pharmaceutical

Buy Now Get Free sample

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

According to publisher, the global Sustained-release Medicine market size was valued at US$ 34090 million in 2023. With growing demand in downstream market, the Sustained-release Medicine is forecast to a readjusted size of US$ 55270 million by 2030 with a CAGR of 7.1% during review period.
The research report highlights the growth potential of the global Sustained-release Medicine market. Sustained-release Medicine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Sustained-release Medicine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Sustained-release Medicine market.
Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.
Since there is no difference between sustained-release preparations and controlled-release preparations in some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D
The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Key Features:
The report on Sustained-release Medicine market reflects various aspects and provide valuable insights into the industry.
The worldwide sustained release medication showcase is thriving, driven by a few key components that upgrade quiet involvement and move forward treatment results.
Market Estimate and Growth
Market estimate estimations change, but the worldwide extended release drugs showcase, which includes sustained release medicines , is anticipated to reach an amazing USD 99.77 billion by 2028, with a development rate of roughly 11.8.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Growth Drivers:
Improved Persistent Compliance Sustained release medicines provide drugs continuously over an amplified period, lessening dosing recurrence. This will essentially progress medicine adherence, particularly for constant conditions like hypertension or ADHD. For occurrence, a once a day ADHD medicine can essentially boost adherence compared to a thrice daily alternative.
Enhanced Restorative Impact Supported release can give steadier sedate levels within the circulatory system, driving to more reliable helpful impacts and possibly minimizing side impacts related with crests and troughs of immediate release medicines. For case, sustained release asthma solutions can offer way better side effect control compared to short acting inhalers.
Chronic Infection Burden The rising predominance of unremitting illnesses like diabetes, cardiovascular afflictions, and neurological disarranges is fuelling the request for sustained release solutions that offer long term administration arrangements.

Challenges and Opportunities:
Development Costs: Creating and getting administrative endorsement for sustained release definitions can be costly and time consuming.
Bioavailability Concerns: Certain sustained-release instruments may influence how much of the medicate is retained by the body, requiring cautious definition plan.

Opportunities:
Technological Advancements: New delivery technologies like microencapsulation can offer more precise drug release profiles and improve bioavailability.
Aging Population: The rising geriatric population with chronic conditions is expected to drive demand for sustained-release medications that enhance medication adherence and ease of use.
Market Size and Growth: The research report provide an overview of the current size and growth of the Sustained-release Medicine market. It may include historical data, market segmentation by Type (e.g., Original Ground Medicine, Generic Medicine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Sustained-release Medicine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Sustained-release Medicine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Sustained-release Medicine industry. This include advancements in Sustained-release Medicine technology, Sustained-release Medicine new entrants, Sustained-release Medicine new investment, and other innovations that are shaping the future of Sustained-release Medicine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Sustained-release Medicine market. It includes factors influencing customer ' purchasing decisions, preferences for Sustained-release Medicine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Sustained-release Medicine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Sustained-release Medicine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Sustained-release Medicine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Sustained-release Medicine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Sustained-release Medicine market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Market Segmentation:
Sustained-release Medicine market is split by Type and by Distribution Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Distribution Channel in terms of value.
Segmentation by type
Original Ground Medicine
Generic Medicine
Segmentation by distribution channel
Hospital
Drugstore
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sanofi
Novartis
Bayer
Johnson & Johnson
Takeda
AstraZeneca
AbbVie
Pfizer
Collegium Pharmaceutical, Inc
Endo Pharmaceuticals
Shanghai Shyndec Pharmaceutical
Zhuhai Rundu Pharmaceutical
China Res Double-Crane

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sustained-release Medicine Market Size 2019-2030
2.1.2 Sustained-release Medicine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Sustained-release Medicine Segment by Type
2.2.1 Original Ground Medicine
2.2.2 Generic Medicine
2.3 Sustained-release Medicine Market Size by Type
2.3.1 Sustained-release Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sustained-release Medicine Market Size Market Share by Type (2019-2024)
2.4 Sustained-release Medicine Segment by Distribution Channel
2.4.1 Hospital
2.4.2 Drugstore
2.4.3 Other
2.5 Sustained-release Medicine Market Size by Distribution Channel
2.5.1 Sustained-release Medicine Market Size CAGR by Distribution Channel (2019 VS 2023 VS 2030)
2.5.2 Global Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
3 Sustained-release Medicine Market Size by Player
3.1 Sustained-release Medicine Market Size Market Share by Players
3.1.1 Global Sustained-release Medicine Revenue by Players (2019-2024)
3.1.2 Global Sustained-release Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Sustained-release Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Sustained-release Medicine by Regions
4.1 Sustained-release Medicine Market Size by Regions (2019-2024)
4.2 Americas Sustained-release Medicine Market Size Growth (2019-2024)
4.3 APAC Sustained-release Medicine Market Size Growth (2019-2024)
4.4 Europe Sustained-release Medicine Market Size Growth (2019-2024)
4.5 Middle East & Africa Sustained-release Medicine Market Size Growth (2019-2024)
5 Americas
5.1 Americas Sustained-release Medicine Market Size by Country (2019-2024)
5.2 Americas Sustained-release Medicine Market Size by Type (2019-2024)
5.3 Americas Sustained-release Medicine Market Size by Distribution Channel (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sustained-release Medicine Market Size by Region (2019-2024)
6.2 APAC Sustained-release Medicine Market Size by Type (2019-2024)
6.3 APAC Sustained-release Medicine Market Size by Distribution Channel (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Sustained-release Medicine by Country (2019-2024)
7.2 Europe Sustained-release Medicine Market Size by Type (2019-2024)
7.3 Europe Sustained-release Medicine Market Size by Distribution Channel (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sustained-release Medicine by Region (2019-2024)
8.2 Middle East & Africa Sustained-release Medicine Market Size by Type (2019-2024)
8.3 Middle East & Africa Sustained-release Medicine Market Size by Distribution Channel (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Sustained-release Medicine Market Forecast
10.1 Global Sustained-release Medicine Forecast by Regions (2025-2030)
10.1.1 Global Sustained-release Medicine Forecast by Regions (2025-2030)
10.1.2 Americas Sustained-release Medicine Forecast
10.1.3 APAC Sustained-release Medicine Forecast
10.1.4 Europe Sustained-release Medicine Forecast
10.1.5 Middle East & Africa Sustained-release Medicine Forecast
10.2 Americas Sustained-release Medicine Forecast by Country (2025-2030)
10.2.1 United States Sustained-release Medicine Market Forecast
10.2.2 Canada Sustained-release Medicine Market Forecast
10.2.3 Mexico Sustained-release Medicine Market Forecast
10.2.4 Brazil Sustained-release Medicine Market Forecast
10.3 APAC Sustained-release Medicine Forecast by Region (2025-2030)
10.3.1 China Sustained-release Medicine Market Forecast
10.3.2 Japan Sustained-release Medicine Market Forecast
10.3.3 Korea Sustained-release Medicine Market Forecast
10.3.4 Southeast Asia Sustained-release Medicine Market Forecast
10.3.5 India Sustained-release Medicine Market Forecast
10.3.6 Australia Sustained-release Medicine Market Forecast
10.4 Europe Sustained-release Medicine Forecast by Country (2025-2030)
10.4.1 Germany Sustained-release Medicine Market Forecast
10.4.2 France Sustained-release Medicine Market Forecast
10.4.3 UK Sustained-release Medicine Market Forecast
10.4.4 Italy Sustained-release Medicine Market Forecast
10.4.5 Russia Sustained-release Medicine Market Forecast
10.5 Middle East & Africa Sustained-release Medicine Forecast by Region (2025-2030)
10.5.1 Egypt Sustained-release Medicine Market Forecast
10.5.2 South Africa Sustained-release Medicine Market Forecast
10.5.3 Israel Sustained-release Medicine Market Forecast
10.5.4 Turkey Sustained-release Medicine Market Forecast
10.5.5 GCC Countries Sustained-release Medicine Market Forecast
10.6 Global Sustained-release Medicine Forecast by Type (2025-2030)
10.7 Global Sustained-release Medicine Forecast by Distribution Channel (2025-2030)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Sustained-release Medicine Product Offered
11.1.3 Sanofi Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Sustained-release Medicine Product Offered
11.2.3 Novartis Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Sustained-release Medicine Product Offered
11.3.3 Bayer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Sustained-release Medicine Product Offered
11.4.3 Johnson & Johnson Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Sustained-release Medicine Product Offered
11.5.3 Takeda Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Sustained-release Medicine Product Offered
11.6.3 AstraZeneca Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Sustained-release Medicine Product Offered
11.7.3 AbbVie Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AbbVie Main Business Overview
11.7.5 AbbVie Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Sustained-release Medicine Product Offered
11.8.3 Pfizer Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Collegium Pharmaceutical, Inc
11.9.1 Collegium Pharmaceutical, Inc Company Information
11.9.2 Collegium Pharmaceutical, Inc Sustained-release Medicine Product Offered
11.9.3 Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Collegium Pharmaceutical, Inc Main Business Overview
11.9.5 Collegium Pharmaceutical, Inc Latest Developments
11.10 Endo Pharmaceuticals
11.10.1 Endo Pharmaceuticals Company Information
11.10.2 Endo Pharmaceuticals Sustained-release Medicine Product Offered
11.10.3 Endo Pharmaceuticals Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Endo Pharmaceuticals Main Business Overview
11.10.5 Endo Pharmaceuticals Latest Developments
11.11 Shanghai Shyndec Pharmaceutical
11.11.1 Shanghai Shyndec Pharmaceutical Company Information
11.11.2 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Offered
11.11.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Shanghai Shyndec Pharmaceutical Main Business Overview
11.11.5 Shanghai Shyndec Pharmaceutical Latest Developments
11.12 Zhuhai Rundu Pharmaceutical
11.12.1 Zhuhai Rundu Pharmaceutical Company Information
11.12.2 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Offered
11.12.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Zhuhai Rundu Pharmaceutical Main Business Overview
11.12.5 Zhuhai Rundu Pharmaceutical Latest Developments
11.13 China Res Double-Crane
11.13.1 China Res Double-Crane Company Information
11.13.2 China Res Double-Crane Sustained-release Medicine Product Offered
11.13.3 China Res Double-Crane Sustained-release Medicine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 China Res Double-Crane Main Business Overview
11.13.5 China Res Double-Crane Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Sustained-release Medicine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Original Ground Medicine
Table 3. Major Players of Generic Medicine
Table 4. Sustained-release Medicine Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Sustained-release Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Sustained-release Medicine Market Size Market Share by Type (2019-2024)
Table 7. Sustained-release Medicine Market Size CAGR by Distribution Channel (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Sustained-release Medicine Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 9. Global Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
Table 10. Global Sustained-release Medicine Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Sustained-release Medicine Revenue Market Share by Player (2019-2024)
Table 12. Sustained-release Medicine Key Players Head office and Products Offered
Table 13. Sustained-release Medicine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Sustained-release Medicine Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Sustained-release Medicine Market Size Market Share by Regions (2019-2024)
Table 18. Global Sustained-release Medicine Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Sustained-release Medicine Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Sustained-release Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Sustained-release Medicine Market Size Market Share by Country (2019-2024)
Table 22. Americas Sustained-release Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Sustained-release Medicine Market Size Market Share by Type (2019-2024)
Table 24. Americas Sustained-release Medicine Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 25. Americas Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
Table 26. APAC Sustained-release Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Sustained-release Medicine Market Size Market Share by Region (2019-2024)
Table 28. APAC Sustained-release Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Sustained-release Medicine Market Size Market Share by Type (2019-2024)
Table 30. APAC Sustained-release Medicine Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 31. APAC Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
Table 32. Europe Sustained-release Medicine Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Sustained-release Medicine Market Size Market Share by Country (2019-2024)
Table 34. Europe Sustained-release Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Sustained-release Medicine Market Size Market Share by Type (2019-2024)
Table 36. Europe Sustained-release Medicine Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 37. Europe Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
Table 38. Middle East & Africa Sustained-release Medicine Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Sustained-release Medicine Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Sustained-release Medicine Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Sustained-release Medicine Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Sustained-release Medicine Market Size by Distribution Channel (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Sustained-release Medicine Market Size Market Share by Distribution Channel (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Sustained-release Medicine
Table 45. Key Market Challenges & Risks of Sustained-release Medicine
Table 46. Key Industry Trends of Sustained-release Medicine
Table 47. Global Sustained-release Medicine Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Sustained-release Medicine Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Sustained-release Medicine Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Sustained-release Medicine Market Size Forecast by Distribution Channel (2025-2030) & ($ Millions)
Table 51. Sanofi Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 52. Sanofi Sustained-release Medicine Product Offered
Table 53. Sanofi Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Novartis Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 57. Novartis Sustained-release Medicine Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Bayer Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 62. Bayer Sustained-release Medicine Product Offered
Table 63. Bayer Main Business
Table 64. Bayer Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Bayer Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 67. Johnson & Johnson Sustained-release Medicine Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Takeda Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 72. Takeda Sustained-release Medicine Product Offered
Table 73. Takeda Main Business
Table 74. Takeda Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Takeda Latest Developments
Table 76. AstraZeneca Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 77. AstraZeneca Sustained-release Medicine Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. AstraZeneca Latest Developments
Table 81. AbbVie Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 82. AbbVie Sustained-release Medicine Product Offered
Table 83. AbbVie Main Business
Table 84. AbbVie Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. AbbVie Latest Developments
Table 86. Pfizer Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 87. Pfizer Sustained-release Medicine Product Offered
Table 88. Pfizer Main Business
Table 89. Pfizer Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Pfizer Latest Developments
Table 91. Collegium Pharmaceutical, Inc Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 92. Collegium Pharmaceutical, Inc Sustained-release Medicine Product Offered
Table 93. Collegium Pharmaceutical, Inc Main Business
Table 94. Collegium Pharmaceutical, Inc Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Collegium Pharmaceutical, Inc Latest Developments
Table 96. Endo Pharmaceuticals Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 97. Endo Pharmaceuticals Sustained-release Medicine Product Offered
Table 98. Endo Pharmaceuticals Main Business
Table 99. Endo Pharmaceuticals Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Endo Pharmaceuticals Latest Developments
Table 101. Shanghai Shyndec Pharmaceutical Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 102. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Offered
Table 103. Shanghai Shyndec Pharmaceutical Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Shanghai Shyndec Pharmaceutical Main Business
Table 105. Shanghai Shyndec Pharmaceutical Latest Developments
Table 106. Zhuhai Rundu Pharmaceutical Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 107. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Offered
Table 108. Zhuhai Rundu Pharmaceutical Main Business
Table 109. Zhuhai Rundu Pharmaceutical Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Zhuhai Rundu Pharmaceutical Latest Developments
Table 111. China Res Double-Crane Details, Company Type, Sustained-release Medicine Area Served and Its Competitors
Table 112. China Res Double-Crane Sustained-release Medicine Product Offered
Table 113. China Res Double-Crane Main Business
Table 114. China Res Double-Crane Sustained-release Medicine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. China Res Double-Crane Latest Developments

Related Reports

Allows one individual to access the purchased report Read More

Coupon Code : BLACK

Allows all employees of an organization to access the purchased report. Internal sharing only Read More

Coupon Code : BLACK

Allows all employees of an organization to access the purchased report. It also permits the use of up to 4 paragraphs or 1 page of the report externally in whitepapers, press releases, and marketing collateral Read More

Coupon Code : BLACK

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Khushi Bhatt

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (03 December, 2024)
Notify To Team (03 December, 2024)
Report updation (04 December, 2024)
Report Quality Check (04 December, 2024)
Report Dispatch (05 December, 2024)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Sustained-release Medicine Market Growth (Status and Outlook) 2024-2030

2024